|
RNA, Catalytic
|
D08.811.797 |
|
|
Cladribine
|
D13.570.800.096.300.200 |
|
|
2-Chloroadenosine
|
D13.570.800.096.300 |
|
|
Dyslipidemias
|
C18.452.584.500 |
|
|
Psychoanalysis
|
F04.096.544.779 |
|
|
Vasculitis, Leukocytoclastic, Cutaneous
|
C14.907.940.910 |
|
|
Lynx
|
B01.050.150.900.649.313.750.377.750.500 |
|
|
Strigiformes
|
B01.050.150.900.248.815.550 |
|
|
Raptors
|
B01.050.150.900.248.815 |
|
|
Neuromyelitis Optica
|
C20.111.258.250.775 |
|
|
Demyelinating Autoimmune Diseases, CNS
|
C20.111.258.250 |
|
|
Adenovirus E1B Proteins
|
D12.776.964.700.045.050.110 |
|
|
Adenovirus E1 Proteins
|
D12.776.964.700.045.050 |
|
|
Alkanesulfonates
|
D02.455.326.146.100.050 |
|
|
Alkanesulfonic Acids
|
D02.455.326.146.100 |
|
|
Inventories, Hospital
|
N04.452.442.452.650.300 |
|
|
Materials Management, Hospital
|
N04.452.442.452.650 |
|
|
Cytophagaceae Infections
|
C01.150.252.400.245 |
|
|
Pulsatile Flow
|
G01.482.620 |
|
|
Vasculitis, Central Nervous System
|
C14.907.940.907 |
|
